Breast cancer detection and treatment: A personal and historical perspective

Archives of Surgery

Volumn 138, Issue 4, 2003, Pages 397-408

  Foster Jr , Roger S ^a,b  

^a EMORY UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CULTURAL FACTOR; HISTORY OF MEDICINE; HUMAN; LYMPHATIC SYSTEM; MASTECTOMY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

AUTOBIOGRAPHY; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CULTURAL CHARACTERISTICS; FEMALE; HISTORY, 16TH CENTURY; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; LYMPHATIC SYSTEM; MASTECTOMY; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 0037389881     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.138.4.397     Document Type: Conference Paper

References (87)

1. Donegan WL. Introduction to the history of breast cancer. In: Donegan WL, Spratt JS, eds. Cancer of the Breast. 4th ed. Philadelphia, Pa: WB Saunders Co; 1995: 1-15.
2. Wagner FB. History of breast disease and its treatment. In: Bland KI, Copeland EM, eds. The Breast: Comprehensive Management of Benign and Malignant Diseases. Philadelphia, Pa: WB Saunders Co; 1991:1-16.
3. Robinson JO. Treatment of breast cancer through the ages. Am J Surg. 1986; 151:317-333.
4. Foster RS Jr. General anatomy of the lymphatic system. Surg Oncol Clin N Am. 1996;5:1-15.
5. Moore CE. On the influence of inadequate operations on the theory of cancer. R Chir Soc. 1867;1:244-280.
6. Küster E. Zur Behandlung des Brustkrebeses. Arch Klin Chir. 1883;29:723-753.
7. Banks WM. A brief history of the operations practiced for cancer of the breast. BMJ. 1902;1:5-10.
8. Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for new treatment with illustrative cases. Lancet. 1896; ii:104-107.
9. Halsted WS. The results of operations for the cure of carcinoma of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann Surg. 1894;20:297-350.
10. Meyer W. An improved method of the radical operation for carcinoma of the breast. Med Rec. 1984;46:746-749.
11. Halsted WS. The results of radical operations for the cure of cancer of the breast. Ann Surg. 1907;46:1-19.
12. Henderson IC, Canellos GP. Cancer of the breast: the past decade. N Engl J Med. 1980;302:17-30.
13. Bloom HJG. Survival of women with untreated breast cancer: past and present. In: Forrest APM, Kunkler PB, eds. Prognostic Factors in Breast Cancer. Baltimore, Md: Williams & Wilkins; 1968.
14. Lewis D, Rienhoff WF. A study of results: Johns Hopkins Hospital, 1889-1931. Ann Surg. 1932;25:336-400.
15. Taylor GW, Wallace RH. Carcinoma of the breast: fifty years experience at the Massachusetts General Hospital. Ann Surg. 1950;132:833-843.
16. Haagensen CD, Miller E. Is radical mastectomy the optimal procedure for early breast carcinoma? JAMA. 1967;199:149-151.
17. Grubbe EH. X-ray Treatment: Its Origin, Birth and Early History, St Paul, Minn: Bruce Publishing; 1949.
18. DelRegato J. Radiotherapy as a postoperative surgical adjuvant in management of cancer of the breast. Radiology. 1971;98:695-698.
19. Williams IG, Murley RS, Curwen MP. Carcinoma of the female breast: conservative and radical surgery. BMJ. 1953;2:787-796,
20. Crile G Jr. The evolution of the treatment of breast cancer. In: Wise L, Johnson H Jr, eds. Breast Cancer: Controversies in Management, Armonk, NY: Futura Publishing Co Inc; 1994.
21. Patey DH, Dyson WH. The prognosis of carcinoma of the breast in relation to the type of operation performed. Br J Cancer. 1948;2:7-13.
22. Handley RS,Thackray AC. Conservative radical mastectomy (Patey's operation). Ann Surg. 1969;170:880-882.
23. Madden JL. Modified radical mastectomy. Surg Gynecol Obstet. 1956;121:1221-1230.
24. Auchincloss H. Significance of location and number of axillary metastases in carcinoma of the breast: a justification for a conservative operation. Ann Surg. 1963; 158:37-46.
25. McWhirter R. The value of simple mastectomy and radiotherapy in the treatment of breast cancer. Br J Radiol. 1948;21:599-610.
26. Ackerman LV. Evaluation of treatment of cancer of the breast at the University of Edinburgh (Scotland) under the direction of Dr Robert McWhirter. Cancer. 1955; 8:883-887.
27. McWhirter R. Should more radical treatment be attempted in breast cancer? AJR Am J Roentgenol. 1964;92:3-13.
28. Keynes G. The treatment of primary carcinoma of the breast with radium. Acta Radiol. 1929;10:393-401.
29. Keynes G. The place of radium in the treatment of cancer of the breast. Ann Surg. 1937;106:619-630.
30. Crile G Jr. Treatment of breast cancer by local excision. Am J Surg. 1965;109: 400-403.
31. Crile G Jr. The smaller the cancer the bigger the operation? rationale of small operations for small tumors and large operations for large tumors. JAMA. 1967; 199:736-738.
32. Crile G Jr. A Biologic Consideration of Treatment of Breast Cancer, Springfield, III: Charles C Thomas Publisher; 1967.
33. Crile G Jr, Hoerr SO. Results of treatment of carcinoma of the breast by local excision. Surg Gynecol Obstet. 1971;132:780-782.
34. Crile G Jr. Breast cancer: a personal perspective. Surg Clin North Am. 1984;64: 1145-1149.
35. Adair FE. The role of surgery and irradiation in cancer of the breast. JAMA. 1943; 121:553-558.
36. Mustakallio S. Treatment of breast cancer by tumor extirpation and roentgen therapy instead of radical operation. J Fac Radiol. 1954;6:23-26.
37. Mustakallio S. Conservative treatment of breast carcinoma: review of 25 years follow up. Clin Radiol. 1972;23:110-116.
38. Baclesse F. Five-year results in 431 breast cancers treated solely by roentgen rays. Ann Surg. 1965;161:103-104.
39. Pierquin B, Owen R, Maylin C, et al. Radical radiation therapy of breast cancer. Int J Radiat Oncol Biol Phys. 1980;6:17-24.
40. Peters MV. Wedge resection and irradiation: an effective treatment in early breast cancer. JAMA. 1967;200:144-145.
41. Peters MV. Wedge resection with or without radiation in early breast cancer. Int J Radiat Oncol Biol Phys. 1977;2:1151-1156.
42. Easson EC, Russell MH. The Curability of Cancer in Various Sites. London, England: Pitman Medical; 1968.
43. Brinkley D, Haybittle JL. A 15-year follow-up study of patients treated for carcinoma of the breast. Br J Radiol. 1968;41:215-221.
44. Brinkley D, Haybittle JL. The curability of breast cancer. Lancet. 1975;2:95-97.
45. Gray JH. The relation of lymphatic vessels to the spread of cancer. Br J Surg. 1938-1939;26:462-472.
46. Fisher ER, Turnbull RB. The cytologic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colo-rectal carcinoma. Surg Gynecol Obstet 1955;100:102-108.
47. Engell HD. Cancer cells in the circulating blood. Acta Chir Scand Suppl. 1955; 201:1-70.
48. Fisher B. Laboratory and clinical research in breast cancer: personal adventure: the David A Karnofsky Lecture. Cancer Res. 1980;40:3863-3874.
49. Early Breast Cancer Trialists' Collaborative Group. Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet. 2000;355:1757-1770.
50. Brinkley D, Haybittle JL. Treatment of stage-II carcinoma of the female breast. Lancet. 1971;2:1086-1087.
51. Bruce J. Operable cancer of the breast: a controlled clinical trial. Cancer. 1971; 28:1443-1452.
52. Cancer Research Campaign Working Party. Cancer Research Campaign (King's/Cambridge) Trial for early breast cancer: a detailed update at the tenth year. Lancet. 1980;2:55-60.
53. Turnbull AR, Chant ADB, Buchanan RB. Treatment of early breast cancer. Lancet. 1978;2:7-9.
54. Langlands AO, Prescott RJ, Hamilton T. A clinical trial in the management of operable breast cancer. Br J Surg. 1980;67:170-174.
55. Kaae S, Johansen H. Breast cancer: five year results: two randomized series of simple mastectomy with postoperative irradiation versus extended mastectomy. AJR Am J Roentgenol. 1962;87:82-88.
56. Kaae S, Johansen H. Simple versus radical mastectomy in primary breast cancer. In: Forrest APM, Kunkler PB, eds. Prognostic Factors in Breast Cancer. Baltimore, Md: Williams & Wilkins; 1968.
57. Lacour J, Monique LE, Caceres E, et al. Radical mastectomy versus radical mastectomy plus internal mammary node dissection: ten year results of an international cooperative trial in breast cancer. Cancer. 1983;51:1941-1943.
58. Veronesi V, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer. 1981;47:170-175.
59. Fisher B, Jeong J-H, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567-575.
60. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333:1456-1461.
61. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991;338:327-331.
62. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials [published correction appears in N Engl J Med. 1995;334:1000-1003]. N Engl J Med. 1995; 333:1444-1455.
63. Patterson R, Russell MH. Clinical trials in malignant disease, part II: breast cancer: value of irradiation of the ovaries. J Fac Radiol. 1959;10:130-133.
64. Early Breast Cancer Trialists' Collaborative Group. Ovarian ablation in early breast cancer: overview of the randomized trials. Lancet. 1996;348:1189-1196.
65. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet. 1998;352:930-942.
66. Wolmark N, Wang J, Mamounas E, et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr. 2001;30:96-102.
67. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998;351:1451-1467.
68. Fisher B, Dignam J, Bryant J, Wolmark N. Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project 8-14 randomization trial. J Natl Cancer Inst. 2001;93:684-690.
69. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1998;90:1371-1388.
70. Haagensen CD. Self-examination of the breasts. JAMA. 1952;149:356-360.
71. Haagensen CD. Carcinoma of the Breast. Monograph for the Physician. New York, NY: American Cancer Society; 1958:7.
72. Way S. Early detection of cancer [letter]. Lancet. 1969;1:53.
73. Foster RS Jr, Lang SP, Costanza MC, et al. Breast self-examination practices and breast cancer stage. N Engl J Med. 1978;299:265-270.
74. Foster RS Jr, Costanza MC. Breast self-examination practices and breast cancer survival. Cancer. 1984;53:999-1005.
75. Shapiro S, Venet W, Strax P, et al. Ten to 14-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982;69:349-355.
76. Gøtzsche PO, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-134.
77. Nyström L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet. 2002; 359:909-919.
78. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137:347-360.
79. Duffy SW, Tabár L, Chen H-H, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer. 2002;95:458-469.
80. Cady B, Stone MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg. 1993;218:338-349.
81. Senie RT, Rosen PP, Lesser ML, Kinne DW. Breast self-examination and medical examination related to breast cancer stage. Am J Public Health. 1981;71:583-590.
82. Rutqvist LE, Wallgren A, Nilsson B. Is breast cancer a curable disease? a study of 14731 women with breast cancer from the cancer registry of Norway. Cancer. 1984;53:1793-1800.
83. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949-955.
84. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997; 337:956-962.
85. Overgaard M, Jensen M-B, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cooperative Group DBCC 82c randomized trial. Lancet. 1999; 353:1641-1648.
86. Foster RS Jr, Farwell ME, Costanza MC. Breast-conserving surgery for breast cancer: patterns of care in a geographic region and estimation of potential applicability. Ann Surg Oncol. 1995;2:275-289.
87. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-1999). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2002, based on the November 2001 submission. Available at: http://seer.cancer.gov/publicdata. Accessed September 19, 2002.